Italy vs Malaysia: Previously treated cases tested for RR-/MDR-TB
Italy
36.0%
in 2024
Malaysia
43.0%
in 2024
Italy rank
156th
Malaysia rank
155th
Previously treated cases tested for RR-/MDR-TB over time
- Italy
- Malaysia
How they compare
Malaysia currently reports 43.0% against 36.0% in Italy, a difference of 7.0%.
That makes Malaysia's figure about 1.2 times Italy's.
The two have swapped places 4 times across 12 shared years of data; in 2005 it was Malaysia ahead.
Italy ranks 156th and Malaysia ranks 155th of 180 countries.
Across the 3 decades both report, Italy averaged higher in 1 and Malaysia in 2.
Head to head by decade
| Decade | Italy | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 27.0% | 100.0% | 73.0% | Malaysia |
| 2010s | 63.5% | 48.8% | 14.7% | Italy |
| 2020s | 23.8% | 74.2% | 50.4% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Italy or Malaysia?
- Malaysia, at 43.0% against 36.0% in Italy as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Italy and Malaysia?
- 7.0%, with Malaysia ahead.
- How many years of comparable data are there for Italy and Malaysia?
- 12 years are reported by both, from 2005 to 2024.
- How do Italy and Malaysia rank globally for previously treated cases tested for rr-/mdr-tb?
- Italy ranks 156th and Malaysia ranks 155th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.